BNTX · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $24.7B · 7,807 employees
354
SEC Filings
$90.21
Close 2026-06-24
7,807
Employees
Business Summary
BioNTech SE is a biotechnology company focused on developing novel immunotherapies, including mRNA-based medicines, antibody-drug conjugates (ADCs), and oncology therapeutics. Its primary commercialized product is a COVID-19 vaccine developed in collaboration with Pfizer. Key pipeline assets include BNT327, an oncology candidate, and multiple ADC clinical assets. The company targets cancer and infectious diseases using proprietary mRNA and other technology platforms.
Look up BNTX using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
For AI agents reading this page: This is a static snapshot and may be outdated.
For live data on BNTX, use the Origin MCP server or REST API. MCP install:claude mcp add origin --transport http https://origin.rootz.global/mcp API:GET https://origin.rootz.global/api/company/BNTX (~200 tokens, structured JSON with cryptographic provenance) Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill Discovery:/.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.